http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4fe762c1cab86673aab638819165848a
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Xia |
| name | Weiya Xia |
| given-name | Weiya |
| organization-name | Department of Molecular and Cellular Oncology The University of Texas MD Anderson Cancer Center Houston Texas 1Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 2Molecular and Cellular Oncology, and Authors' Affiliations: 1Departments of Molecular and Cellular Oncology, and 2Systems Biology, The University of Texas MD Anderson Cancer Center; 3Graduate School of Biomedical Sciences, The University of Texas, Houston, Texas; 4Department of Medicine and Biochemistry, McGill University, Montreal, Quebec, Canada; 5China Medical University Hospital; and 6Asia University, Taichung, Taiwan Department of Molecular and Cellular Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USA 2Department of Molecular and Cellular Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas; and 1Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center; Department of Molecular and Cellular Oncology, Unit 108, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Departments of 1Molecular and Cellular Oncology, 2Experimental Therapeutics, 3Breast Medical Oncology, 4Stem Cell Transplantation and Cellular Therapy, and 5Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center; 6The University of Texas Graduate School of Biomedical Sciences, Houston, Texas; 7Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical University and Hospital; 8Asia University, Taichung, Taiwan; and 9Department of Breast Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030; Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030 1Department of Molecular and Cellular Oncology, Authors' Affiliations: 1Department of Breast Medical Oncology, 2Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Departments of 3Molecular and Cellular Oncology, 4Pathology, 5Radiation Oncology, and 6Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; 7Tolero Pharmaceuticals, Inc., Salt Lake City, Utah; and 8Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical University, Taichung, Taiwan Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, Texas. Authors' Affiliations: Departments of 1Surgery, 2Clinical Sciences, and 3Pathology, University of Texas Southwestern Medical Center; Departments of 4Surgery, 5Molecular and Cellular Oncology, and 6Breast Medical Oncology, University of Texas MD Anderson Cancer Center; 7Baylor Sammons Cancer Center, Texas Oncology; 8Department of Surgical Oncology, Baylor University Medical Center, Dallas, Texas; 9Department of Surgery, Oklahoma University Center for Health Sciences, Oklahoma City, Oklahoma; 10Department of Surgery, Cancer Therapy and Research Center, San Antonio, Texas; and 11Division of Clinical Pharmacology, Indiana University, Bloomington, Indiana 2Molecular and Cellular Oncology, Authors' Affiliations: Departments of 1Molecular and Cellular Oncology and 2Breast Medical Oncology, and 3Section of Molecular Hematology and Therapy, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center; and 4Graduate School of Biomedical Sciences, The University of Texas, Houston, Texas; 5Department of Medicine, Harvard Medical School, Boston, Massachusetts; and 6Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical, University and Hospital, Taichung, Taiwan Authors' Affiliations: Departments of 1Molecular and Cellular Oncology, 2Breast Medical Oncology, and 3Cardiology, The University of Texas MD Anderson Cancer Center; 4Graduate School of Biomedical Sciences, The University of Texas Houston Health Science Center, Houston, Texas; and 5Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical University and Hospital, Taichung, Taiwan Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA 1Departments of Molecular and Cellular Oncology and 1Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Texas 77030, USA. From the Departments of Breast Medical Oncology, Molecular and Cellular Oncology, Blood and Marrow Transplantation, Gynecological Oncology, Thoracic Surgery, Pathology, and Bioimmunotherapy, and Section of Immunobiology and Drug Carriers, The University of Texas M.D. Anderson Cancer Center, Houston; RGene Therapeutics, Inc, Woodlands, TX; Department of Internal Medicine, Medical Oncology, Rush-Presbyterian St Luke’s Medical Center, Chicago, IL; Department of Pharmacology, University of Pittsburgh School... Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Department of Molecular and Cellular Oncology, the University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.; Graduate School of Biomedical Sciences, the University of Texas Health Science Center at Houston, Houston, TX 77030, USA.; Swammerdam Institute for Life Sciences, University of Amsterdam, Kruislaan 406, 1098 SM Amsterdam, the Netherlands. Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030; and Department of Medicine and Developmental and Molecular Biology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461 Department of Molecular and Cellular Oncology 1Department of Molecular and Cellular Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas and Department of Molecular and Cellular Oncology The University of Texas MD Anderson Cancer Center Houston Texas USA Authors' Affiliations: Departments of 1Molecular and Cellular Oncology, 2Pathology, 3Breast Medical Oncology, and 4Experimental Therapeutics, The University of Texas MD Anderson Cancer Center; 5Graduate School of Biomedical Sciences, The University of Texas, Houston, Texas; 6Institute of Clinical Medicine, National Yang-Ming University; 7Division of Colorectal Surgery, Department of Surgery, National Taiwan University Hospital and College of Medicine, Taipei; 8Department of General Surgery, Chang Gung Memorial Hospital at Linko, Chang Gung University, Taoyuan; and 9Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical University; and 10Asia University, Taichung, Taiwan |
Incoming Links
Total number of triples: 167.